Clinical trial
YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver…
NCT00450398 · Y's Therapeutics, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00450398 |
|---|---|
| Title | YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation |
| Official title | A Controlled, Prospective, Blinded, Randomized, Single-Center, Study of YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation |
| Lead sponsor | Y's Therapeutics, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Diseases |
| Intervention type | Drug |
| Interventions | YSPSL, Placebo |
| Enrollment | 12 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Mar 22, 2007 |
| Last update posted | Jan 29, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: